SEC Tracker
Get the app

Aptevo Therapeutics APVO

Aptevo Therapeutics announces 10 AML patients advanced to transplant

Item 8.01 Other events

Form
8-K
Filed
Importance
Routine
  1. 10 patients with AML advanced to allogeneic stem cell transplant
  2. Treatment included mipletamig with venetoclax and azacitidine

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aptevo Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Traws Pharma ONTX public float $10M, Jun 30, 2025
  2. Mannatech MTEX public float $10M, Jun 30, 2025
  3. LeonaBio ATHA public float $10M, Jun 30, 2025
  4. BioCardia BCDA public float $10M, Jun 30, 2025
  5. Alaunos Therapeutics TCRT public float $10M, Jun 30, 2025